Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging... Show more
BIOA moved above its 50-day moving average on May 22, 2025 date and that indicates a change from a downward trend to an upward trend. In of 1 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .
The Momentum Indicator moved above the 0 level on May 29, 2025. You may want to consider a long position or call options on BIOA as a result. In of 11 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for BIOA just turned positive on June 02, 2025. Looking at past instances where BIOA's MACD turned positive, the stock continued to rise in of 3 cases over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where BIOA advanced for three days, in of 36 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows